Rosalind Advisors »

Vistagen Therapeutics shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Vistagen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $0 493k 0.00

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Vistagen Therapeutics

Rosalind Advisors
Simplex Trading
Group One Trading
Persistent Asset Partners

View all funds holding Vistagen Therapeutics